CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Question 12: Which of these statements was NOT made by one of the members of Venturis Therapeutics’s leadership team at one of the annual shareholders meetings?

(By popular demand, we are re-visiting this subject from Question 11 with new and different quotes. There's a link to Question 11 below if you did not see it the first time.)

A) Calvin Wallen III: "Dr. Meyerson has been published over 100 times, and information on him is available on the Internet. You can see his publications, track record, what he has done in the industry. He is a strong biotech influence on the company."" (2018)

B) Grant Gordon: "Alright, I'm a high school dropout, I can own that. And I'm an alcoholic and have been drinking continually for over 4 decades, it's just the way it is. And maybe I'm not the most reliable person on the planet. But that doesn't mean that when I tell you that Venturis is about to close on a huge sum of equity, or that the clinical trials are about to re-start, or that Calvin Wallen is innocent of the charges filed against him by the U.S. government for allegedly stealing $14 million from his previous company, it doesn't mean I'm not telling the truth. Because if I said it, I believe it to be true. Isn't that enough for all of you? Thank you." (2020)

C) Calvin Wallen III: "We hope to the bring to the marketplace over the next 12 months news of what we are hoping to enjoy." (2016)

D) Jon Ross: "There is one employee being compensated in cash by the company." (2016)

E) Robert Schleizer: "The company had a net loss of $2.8 million in 2017." (2018)

F) Calvin Wallen: "We've been working hard." (2018)

(The correct answer is listed below)

This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105

The correct answer is: (B). This was again easy, for two reasons. One, because Venturis Therapeutics did not hold a shareholders meeting in 2020--in violation of its bylaws and stated promises to shareholders. Two, because since Calvin Wallen's hostile takeover, Grant Gordon has never spoken at a shareholders meeting (Mr. Wallen probably doesn't dare risk it). If you chose any answer other than (B), you really haven't been paying attention.

For fun, let's go through and review each of these choices.

(A) I remember laughing out loud at this statement when Mr. Wallen made it, because in one paragraph it reveals Calvin Wallen's complete buffoonery. Breaking News: Dr. Meyerson's career has been in pharmaceuticals, not biotechnology. But to a dropout like Mr. Wallen who doesn't know a protein from a chemical, what's the difference? And I love that final sentence, "He's a strong biotech influence on the company." Boy is that ever a statement.

(C) This is another Calvin Wallen doozy that had me laughing out loud at the time he made it. File this one under, "A statement that reflects the quality of the mind it came from." If you have any idea what his confused mind was trying to say, please let us all know. Does anyone know if Calvin Wallen III went by the name Nigel Tufnel earlier in life?

(D) Yes, I also loved this Jon Ross statement, in response to a question posed by a shareholder. Mr. Ross's statement reflects the stench of the company...er, I mean strength, that they only were paying one employee in cash. Mr. Ross proved Calvin Wallen's point that if you want to look smarter, surround yourself with dumber people. Also, by some strange coincidence, it's the last time that Mr. Ross ever spoke at a shareholders meeting. I wonder why?

(E) This quote is significant because it's the only time during the Calvin Wallen era we've ever been told any financial information about the company. Of course, in the next sentence Mr. Schleizer also indicated that the company received a going concern qualification from its auditors.

(F) When Mr. Wallen told us in 2018 that "We've been working hard," every shareholder breathed a sigh of relief. Because based on the non-existent results from CVBT/Venturis, we were all wondering if anyone was actually working beyond the one employee being paid in cash. Thankfully Mr. Wallen re-assured us they were.

Maybe this is a good time to review what a high-placed Venturis Therapeutics insider who left the company had to say:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999

And here are the earlier questions in our series:

Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885

Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166

Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431

Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684

Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065

Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658

Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920

Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390

Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737

Question 10: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356

Question 11: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156983504